|
Generic Name : Palivizumab
Pronunciation : pal-i-VIZ-u-mab
Trade Name(s):
International- Synagis. This medication is a monoclonal antibody, prescribed for respiratory syncytial virus (RSV) disease in pediatric patients. When it is not to be taken (Contraindications):
When it is to be taken : Adult- IM- The recommended dose is 15 mg/kg of body weight. How it should be taken : It comes as a solution for injection to be administered by a healthcare provider into a large muscle. Special Instruction : * Caution should be exercised in patients with history of bleeding disorder or low platelet count, heart surgery, who are taking anticoagulants, any allergy, during pregnancy and breastfeeding. Side Effects : Most Common - Respiratory tract infection, ear infection, fever, nose inflammation, rash, diarrhea, cough, vomiting, stomach flu, and wheezing. * Avoid excess dosage. Storage Conditions : Store it in refrigerator (2° to 8°C) and in an airtight container. Do not freeze it. |
![]() Comment & Contribute
![]()
![]() ![]() | ||


